A disruption in fractalkine-CX3CR1 signaling by opiate-HIV protein exposure would parallel evidence from a variety of other CNS disorders where fractalkine-CX3CR1 interfacing appears to be altered, including Parkinson's and Alzheimer's diseases, as well as in HIV dementia [40,44,72]. The gene discussed is CX3CR1; the disease is Parkinsonism.